Wyrob Tablet contains Ornidazole 500 mg, an antiprotozoal and antibacterial agent primarily used to treat infections caused by anaerobic bacteria and protozoa. Ornidazole belongs to the nitroimidazole class of drugs and exerts its therapeutic effect by disrupting the DNA synthesis of susceptible microorganisms, leading to their death. Wyrob Tablet is commonly prescribed for the management of various infections including amoebiasis, giardiasis, trichomoniasis, and bacterial vaginosis, as well as anaerobic bacterial infections of the gastrointestinal tract, genitourinary system, skin, and soft tissues. It is also effective in the treatment of pelvic inflammatory disease and postoperative infections. The recommended dosage and duration of therapy depend on the type and severity of the infection and should be determined by a healthcare professional. Patients are advised to complete the full course of treatment to prevent the development of resistance. Common side effects may include nausea, metallic taste, dizziness, and gastrointestinal discomfort. Caution is advised in patients with hepatic or renal impairment, and it is contraindicated in individuals with hypersensitivity to nitroimidazoles. Pregnant or breastfeeding women should consult their physician before use. Wyrob Tablet should be stored in a cool, dry place away from direct sunlight and kept out of reach of children.